Anti-Grey Hair Serums: The Science, Market Surge, and What Men Need to Know

Key Highlights
Introduction
Why grey hair matters to men now
What causes hair to grey: the biology you need to understand
The rise of anti-grey hair serums: demand, data and market trajectories
How peptide-based formulas propose to intervene
Antioxidants, catalase and the hydrogen peroxide hypothesis
Preventative serums versus temporary dyes and supplements: where each fits
Real-world examples and industry responses
Evaluating evidence: what counts as credible claims?
Formulation hurdles: why translating lab results into real-world effects is hard
Regulatory and safety considerations
Practical guidance: what to look for when choosing an anti-grey serum
Lifestyle and systemic levers that influence greying
The hair care market’s longevity shift and commercial implications
Research frontiers: where the science might head next
Case study: consumer adoption patterns and a brand response
Common red flags in anti-grey hair product claims
How professionals view topical anti-grey interventions
Cost, accessibility and consumer expectations
Where the category is vulnerable
Practical regimen for someone starting an anti-grey serum
FAQ

Key Highlights

Anti-grey hair serums are experiencing explosive consumer interest—searches for "anti-grey hair serum" have grown by more than 1,000% year-over-year, and the broader anti-grey category rose 154% in the past year.
Advances in peptide-based cosmetic chemistry, scalp-targeted delivery systems, and an ageing-aware male grooming market are shifting demand from temporary dyes toward preventative, topical solutions.
Choosing an effective serum requires scrutiny of ingredients, delivery technology, clinical evidence and realistic expectations about outcomes and timelines.

Introduction

Grey hair has shifted from a cosmetic inevitability to a target for prevention. Once accepted as a visible sign of ageing, greying now sits at the center of product innovation and consumer anxiety: a recent joint survey by Talker Research and Just for Men found 65% of men wish they could prevent grey hairs. Search and social metrics reflect that urgency—market intelligence firms report triple- and quadruple-digit growth in searches and attention for anti-grey hair solutions. Brands and chemists have responded with a new generation of topical serums that promise to slow or reverse greying through targeted biochemical mechanisms rather than masking hair with dyes.

This article maps the landscape of anti-grey hair serums: why demand has accelerated, what biologically causes hair to grey, how modern peptide-based formulas and delivery systems claim to intervene, how the category compares to dyes and supplements, and what consumers and professionals should look for when evaluating efficacy and safety. The shift toward scalp-focused, longevity-oriented hair care sits alongside a projected $80 billion scalp care market by 2032, indicating commercial muscle behind scientific innovation. Below, the science meets the market—and practical guidance meets skepticism—so readers can separate plausible progress from marketing hyperbole.

Why grey hair matters to men now

Surveys show a notable attitudinal pivot among men toward appearance and ageing. Just for Men’s consumer research and complementary market studies indicate younger male cohorts are placing more emphasis on aesthetics than previous generations: 68% of Gen Z and millennial men said they care more about their appearance than five years ago and nearly 60% indicated concern about signs of ageing. That shift flows into purchase behavior. Digital platforms amplify visual norms and accelerate awareness: influencers, tutorials, and before/after posts make greying an addressable issue rather than an inevitability.

Search behavior reinforces the trend. Intelligence from Spate reports “anti-grey hair serum” searches rocketing by over 1,000% year-over-year. Market analysis firm Glimpse measured a 154% growth in the anti-grey hair care market in the past year. Consumer appetite is not only about cosmetics: many men want prevention rather than cover-up. The shift toward preventative solutions is analogous to trends observed earlier in skincare, where “longevity” products—those aimed at preserving tissue function and appearance over time—have overtaken purely corrective or concealing products.

The commercial response is visible across categories. Major players in men’s grooming are expanding beyond dyes and toning shampoos into topical actives, and indie brands are launching targeted serums with biotech-inspired claims. Industry events and awards are adjusting to the trend: the Pure Beauty Awards 2026, for example, call for entries of innovations launched in the past 12 months, signaling category maturation and competitive interest.

What causes hair to grey: the biology you need to understand

Hair colour derives from melanin produced by melanocytes at the base of hair follicles. Two main forms—eumelanin (brown/black) and pheomelanin (red/yellow)—determine pigmentation. Greying occurs when melanin production diminishes or stops entirely in individual follicles. Several biological processes drive that decline:

Melanocyte stem cell depletion: The stem cells that regenerate pigment-producing melanocytes can be exhausted over time. When those progenitors fail to replenish mature melanocytes during hair growth cycles, hair emerges with reduced pigment.
Oxidative stress and hydrogen peroxide buildup: Metabolic activity in the follicle generates reactive oxygen species (ROS). Accumulation of hydrogen peroxide (H2O2) in hair follicles has been implicated in depigmentation by impairing key enzymes responsible for melanin synthesis.
Decline in melanogenic enzymes: Tyrosinase and related enzymes catalyze melanin synthesis. Reduced activity or expression of these enzymes leads to lower pigment production.
Genetic programming: Genetic variants influence the timing and rate of greying—some people grey in their 20s, others not until later life. Genome-wide association studies have identified loci associated with hair greying and pigmentation.
Systemic factors and disease: Nutritional deficiencies (notably vitamin B12), autoimmune conditions, and certain dermatologic disorders can accelerate or precipitate greying. Smoking and certain medications also correlate with earlier greying.
Local inflammation and microenvironment changes: Scalp health, microvascular supply and localized inflammation can affect follicle function and melanocyte viability.

Understanding these mechanisms explains why different interventions target different stages—some aim to protect melanocytes from oxidative damage, others to stimulate melanogenic signaling, and still others to replace lost pigment synthetically (dyes) or through external coloring agents.

The rise of anti-grey hair serums: demand, data and market trajectories

Market signals converge on a rapid expansion of anti-grey hair serums as a discrete category. Key data points:

Glimpse reports the anti-grey category grew 154% year-over-year, indicating demand is accelerating beyond novelty interest.
Spate finds search interest for “anti-grey hair serum” increased by more than 1,000% year-over-year, reflecting strong consumer curiosity and intent.
Statista projects the anti-ageing hair care market will grow at approximately 6% CAGR to 2032, while the scalp care market is forecast to approach nearly US$80 billion by the same year.

Why are serums central to this growth? Serums offer concentrated actives in a vehicle that facilitates follicular targeting. They position themselves as a middle ground between one-off cosmetic solutions (temporary dyes) and systemic interventions (oral supplements). That positioning matches consumer preference for topical, non-invasive, routine-friendly products that promise cumulative benefits when used consistently.

Brands are capitalizing on this opportunity with tailored positioning: treatments for early greying, maintenance protocols for those who have chemically colored their hair, and combination offerings that pair pigment-supporting actives with general scalp health ingredients. Media coverage and influencer demonstrations amplify reach; a single viral transformation can drive rapid sales spikes for niche brands.

How peptide-based formulas propose to intervene

Peptides form a major pillar of contemporary topical innovation across skin and hair. In anti-grey formulations, peptides claim several functional roles:

Signaling to melanogenesis: Certain short peptides can mimic endogenous signaling peptides or modulate receptor pathways that promote melanin production. By activating melanogenic pathways, these peptides aim to increase dye enzyme activity or melanocyte function.
Cellular protection: Peptides with antioxidant properties or those that promote cellular repair can reduce the oxidative burden on follicular melanocytes, limiting hydrogen peroxide–mediated damage.
Copper-binding and enzymatic support: Some peptide constructs are designed to bind copper, an essential cofactor for tyrosinase. Stabilizing cofactor availability can support enzymatic activity involved in melanin synthesis.
Modulating niche factors: Peptides can influence extracellular matrix interactions and cell–cell communication within the follicular niche, preserving or encouraging melanocyte stem cell activity.

The term “patented peptide-based formulas” describes proprietary sequences or conjugates engineered to act on specific molecular targets. Successful translation from bench to bottle requires addressing three technical challenges: ensuring peptides reach the hair follicle in bioactive form; confirming the peptide engages its intended target in vivo; and demonstrating meaningful, observable pigment changes on a clinically relevant timeline.

Delivery systems matter. Follicular penetration is limited by skin and hair shaft barriers. Formulators use strategies such as:

Low-viscosity vehicles that favor follicular seepage.
Encapsulation in liposomes, niosomes or polymeric nanoparticles to protect peptides from degradation and improve follicle targeting.
Use of penetration enhancers at safe concentrations or micellar carriers that increase solubility and transit through sebum-rich environments.

Evidence standards vary. A growing number of brands publish in-vitro data showing increased tyrosinase activity or reduced ROS, but robust clinical trials—with randomized, placebo-controlled designs and objective pigment assessment—are still relatively scarce. Consumers should privilege products with published, peer-reviewed clinical data showing quantifiable repigmentation or prevention outcomes.

Antioxidants, catalase and the hydrogen peroxide hypothesis

Hydrogen peroxide accumulation in hair follicles oxidizes critical proteins and inhibits tyrosinase activity. The hydrogen peroxide hypothesis of greying suggests that increasing local antioxidant capacity or enhancing catalase activity (the enzyme that degrades H2O2 to water and oxygen) can protect melanocytes and preserve pigment.

Topical approaches that target oxidative stress include:

Direct antioxidants (vitamin C, vitamin E, ferulic acid) aimed at neutralizing ROS.
Ingredients that support endogenous antioxidant systems (NAD+ boosters, certain peptides).
Formulations that claim to enhance catalase activity or supply catalase-like actions.

Clinical data for antioxidant approaches show mixed results. Oxidative stress is a plausible contributor to greying, but reversing established depigmentation likely requires restoring melanocyte function—mere antioxidant supplementation may slow progression more reliably than it restores lost pigment.

Preventative serums versus temporary dyes and supplements: where each fits

Consumers face three broad categories of solutions, each with distinct mechanisms, timelines and expectations:

Temporary and permanent dyes: These provide immediate visual change. Semi-permanent and temporary dyes coat the hair shaft, while permanent oxidative dyes chemically alter pigment within the hair cortex. Dyes are reliable for immediate coverage but require maintenance and may damage hair structure over repeated applications.
Oral supplements: Nutraceuticals claim to address systemic contributors—nutrient deficiencies, oxidative stress and metabolic factors. Evidence for oral supplements specifically reversing greying is limited; supplements support overall hair health but rarely restore pigment on their own unless a deficiency (e.g., vitamin B12) is causative.
Topical, preventative serums: These aim to preserve or restore follicular pigment by targeting melanocyte biology, reducing oxidative stress, or providing biochemical cofactors. They require consistent application and time—clinical claims typically reference months rather than weeks.

Choosing between these approaches depends on priorities. For immediate cosmetic needs, dyeing remains the most reliable method. For long-term pigment maintenance, serums that rely on plausible biological mechanisms offer an appealing alternative, provided consumers accept a gradual timeline and seek products with credible data.

Real-world examples and industry responses

Brands and manufacturers across the hair care spectrum are responding. Just for Men’s consumer research underscores the commercial opportunity and informs product roadmaps for legacy players that historically focused on dyes. Indie biotech-focused brands are marketing peptide serums with laboratory claims and sometimes limited clinical studies.

Industry recognition follows innovation: awards programs are adapting to highlight new anti-grey formulations. The Pure Beauty Awards 2026 is explicitly inviting entries for innovative products launched in the past 12 months, reflecting how mainstream beauty institutions view anti-grey solutions as a growth category rather than a niche curiosity.

Retail behavior shows signs of adoption beyond early adopters. Search spikes produce sales for targeted serums on e-commerce platforms, and routine-driven grooming regimens—morning serums applied to the scalp or nightly treatments—are gaining traction in male-focused grooming routines. Salons and barbers are also beginning to stock topical maintenance products, integrating them into coloring or maintenance services.

Evaluating evidence: what counts as credible claims?

Marketing for anti-grey serums commonly uses scientific language. Consumers and professionals should evaluate claims by asking specific questions:

Are there randomized, placebo-controlled trials in humans demonstrating pigment retention or repigmentation? Look for objective measures (phototrichograms, standardized colorimetry) and clinically meaningful endpoints.
What is the sample size and demographic variability in trials? Pigment recovery may differ by age, ethnicity, and extent of greying.
Is the mechanism plausible and consistent with current hair biology? Mechanistic in-vitro data are supportive but not definitive.
Are results replicated by independent researchers or published in peer-reviewed journals? Independent validation reduces bias risk.
Does the product disclose active concentrations and vehicle technology? Active ingredients at negligible concentrations may be ineffective despite claims.
Are safety data and adverse event monitoring available? Long-term topical application requires dermatologic tolerability.

Products that provide transparent trial data—clear endpoints, control arms, and quantitative results—merit stronger consideration than those relying solely on consumer testimonials or in vitro assays.

Formulation hurdles: why translating lab results into real-world effects is hard

Beautifying hair pigment via topical actives is scientifically plausible but practically challenging. Key barriers include:

Follicle access: The hair follicle is a protected niche. Actives must traverse the stratum corneum, sebum environment, and follicular architecture to reach melanocytes effectively.
Molecular stability: Peptides and enzymes can degrade at room temperature or in the presence of proteases present on the skin. Stabilization strategies increase formulation complexity and cost.
Concentration and dosing: Biological effects typically require threshold doses. Cosmetic formulations often balance performance against sensory characteristics and regulatory limits, which can lead to sub-therapeutic active levels.
Inter-individual variability: Genetics, hair cycle stage, and existing follicular damage cause heterogenous responses. Some users may see visible improvements; others may not.
Timeframe: Hair grows ~1–1.5 cm per month. Even if follicular pigment resumes, visible change appears only when pigmented hair is produced and emerges from the follicle—typically months.

These hurdles explain why many early claims are tentative and why clinicians approach new products with cautious optimism.

Regulatory and safety considerations

The regulatory status of anti-grey serums depends on claims. In many jurisdictions, topical products marketed as cosmetics can legally improve the appearance of hair without making disease claims. However, claims that a product “rests melanocyte function” or “restores pigmentation” risk crossing into drug territory, triggering stricter regulatory oversight.

Safety considerations include:

Sensitization: Repeated topical exposure to novel peptides or delivery enhancers can cause allergic contact dermatitis in susceptible individuals.
Unintended pigmentation: Ingredients that affect melanocyte activity might influence pigmentation in adjacent skin in rare cases.
Interaction with dyes: Serums used alongside oxidative dyes may interact chemically, potentially altering dye uptake or hair integrity.
Long-term effects: Limited long-term safety data exist for many novel peptide constructs; ongoing surveillance and post-market data are essential.

Consumers should seek products with clear safety profiles, dermatologic testing, and transparent labeling. Professionals evaluating these products—dermatologists, trichologists and regulatory experts—should scrutinize both clinical data and manufacturing quality controls.

Practical guidance: what to look for when choosing an anti-grey serum

The market contains a mix of evidence-backed products and those leveraging trend-driven marketing. Use the following checklist when assessing options:

Clinical evidence: Prioritize products with randomized, controlled trials demonstrating pigment preservation or regrowth. Objective measurements and photographs under standardized conditions matter.
Ingredient transparency: Look for clearly listed active ingredients and their concentrations. Proprietary blends without disclosure make independent assessment difficult.
Delivery technology: Serums that describe follicular delivery mechanisms, encapsulation strategies or vehicles optimized for sebum-rich environments have a formulation advantage.
Safety and tolerability: Dermatologic testing, patch test data and adverse event reporting should be available.
Realistic timelines: Expect at least three to six months of consistent use before judging efficacy. Companies that promise overnight reversal are unlikely to deliver biologically plausible results.
Complementary regimen: Products that pair serums with scalp-care routines—gentle cleansing, anti-inflammatory care and sun protection—address the broader follicle environment.
Professional endorsement and independent reviews: Look for endorsements from dermatologists or trichologists with no undisclosed conflicts of interest, as well as balanced independent consumer reviews.

Apply a skeptical lens to marketing language that implies a single-ingredient “magic bullet.” Repigmentation, where achievable, likely results from multifactorial support: antioxidant protection, melanocyte stimulation, nutrient availability and a healthy follicular microenvironment.

Lifestyle and systemic levers that influence greying

Topical interventions are one piece of the puzzle. Addressing systemic contributors can complement serums and improve overall hair health:

Smoking cessation: Smoking accelerates oxidative stress and associates with earlier greying.
Nutrition: Ensure adequate intake of vitamin B12, folate and other micronutrients implicated in hair health. Deficiencies should be corrected under clinical guidance.
Stress management: Chronic stress correlates with physiological changes that may influence hair cycling and oxidative damage. Stress reduction practices have general health benefits.
Medical evaluation: If greying occurs at a very early age, clinicians should assess for underlying causes—autoimmune disorders, thyroid disease or nutritional deficiencies.
Scalp hygiene and inflammation control: Chronic scalp inflammation can disrupt follicle function; anti-inflammatory approaches and managing dandruff or seborrheic dermatitis help maintain a healthier follicular niche.

Combining lifestyle interventions with topical serums provides a more holistic approach and improves odds of a favorable outcome.

The hair care market’s longevity shift and commercial implications

The longevity trend that started in skincare is reshaping hair care. Consumers increasingly seek products that preserve biological function as much as they conceal changes. That shift manifests in several commercial and research trajectories:

Investment in R&D: Larger players and biotech startups are allocating R&D budgets to follicular biology and scalable topical delivery systems.
Clinical rigor as a market differentiator: Brands that produce robust clinical evidence will gain credibility and command premium positioning.
Retail and professional channels: Salons and barbers can act as points of education and adoption, offering treatments and ongoing scalp maintenance protocols.
Mergers and acquisitions: Consolidation is likely as mainstream personal care companies acquire biotech-lit brands to accelerate product pipelines.
Regulatory scrutiny: As claims grow more ambitious, expect regulators to scrutinize whether products cross from cosmetics into therapeutic claims, affecting marketing and approval requirements.

The scalp care market’s forecasted near-US$80 billion size by 2032 signals that investment will follow consumers. That investment should drive better formulations, but it also increases the need for evidence-based differentiation.

Research frontiers: where the science might head next

Current advances suggest several promising avenues:

Targeted melanocyte stem cell modulation: Strategies that preserve or rejuvenate melanocyte stem cells could alter the natural course of greying.
Gene modulation: Gene-editing or gene-expression strategies might one day offer durable solutions, though delivery and safety present hurdles.
Microbiome influence: Emerging research links the skin and scalp microbiome to local inflammation and barrier function, offering a potential indirect route to support follicle health.
Improved biomarkers: Advanced imaging and molecular markers can enable more sensitive detection of early efficacy in trials, accelerating product validation.
Combination therapies: Pairing topical peptides with localized low-level light therapy or microdelivery methods might amplify efficacy.

Any of these pathways will require rigorous clinical validation before becoming mainstream. For now, the most accessible advances lie in smarter peptide chemistry, improved delivery systems and better-designed clinical trials.

Case study: consumer adoption patterns and a brand response

A practical illustration comes from Just for Men’s consumer research and market experiments. Their survey with Talker Research found 65% of men would prefer to prevent grey hairs. That consumer insight has moved the brand and similar legacy players to expand beyond dyes into maintenance and prevention messaging. Some brands now position products as part of a multistep routine: cleanse with scalp-friendly shampoos, apply peptide-rich serums daily, and supplement with nutrient support when deficiencies are identified.

Real-world adoption follows predictable stages: early adopters and image-conscious consumers experiment first, social proof via influencers and before/after imagery drives broader interest, and then sustained efficacy—or lack thereof—determines long-term category retention. Brands that integrate clinician-led endorsements and transparent clinical data report higher repurchase rates.

Common red flags in anti-grey hair product claims

Consumers should watch for the following warning signs:

Overstated timelines: Guarantees of reversal within weeks are biologically implausible.
Lack of ingredient transparency: “Proprietary blends” without active concentrations provided should be treated cautiously.
Exclusively in-vitro data: Lab results are useful but not proof of clinical efficacy.
Celebrity endorsements without clinical backing: Marketing may conflate anecdote with evidence.
Claims of complete reversal for all hair types: Inter-individual variability makes universal claims suspect.

When in doubt, consult a dermatologist or trichologist before committing to a long-term purchase.

How professionals view topical anti-grey interventions

Dermatologists and hair specialists regard topical serums with reasoned optimism tempered by clinical standards. Key perspectives from clinicians include:

Support for preventive strategies: Protecting follicular health through scalp care, nutrition and smoking cessation is foundational.
Demand for high-quality trial data: Clinical proof in diverse populations with objective endpoints builds confidence.
Practical use-cases: Serums may be most useful for early-stage greying or as maintenance after color treatments, rather than as an assured reversal for established grey hair.
Cautions about allergic reactions: Patch testing and supervision are recommended for patients with sensitive skin or scalp conditions.

Professionals will adopt serums into practice as RCT-grade evidence accumulates and as post-market surveillance clarifies safety profiles.

Cost, accessibility and consumer expectations

Price points for anti-grey serums vary widely. Novel peptide formulations with delivery technology and clinical backing command premium prices. Low-cost competitors may trade on trend-driven marketing, offering less rigorous formulations. Consumers should weigh cost against evidence and realistic outcome timelines.

Accessibility is expanding through e-commerce channels, subscription models and direct-to-consumer brands. Insurance does not cover cosmetic hair treatments, so consumers bear the full financial cost. Brands that offer trial-size formats or money-back guarantees reduce upfront risk for consumers, but guarantees should be read alongside the product’s scientific documentation.

Where the category is vulnerable

Several factors could slow or reshape the anti-grey serum market:

Efficacy plateau: If real-world results diverge from marketing promises, consumer trust could erode.
Regulatory tightening: Stricter definitions of drug claims may force reclassification and slow product rollouts.
Competitive substitutes: New oral therapeutics or in-clinic procedures could draw investment away from topicals.
Price sensitivity: Premium pricing limits broad adoption if results don’t match expectations.

Despite these vulnerabilities, current demand signals and investment point toward continued expansion and richer clinical inquiry.

Practical regimen for someone starting an anti-grey serum

A pragmatic regimen aligns expectations with biology:

Baseline assessment: Photograph the scalp and hair, note greying pattern and consult a clinician if greying is early or rapidly progressive.
Address systemic factors: Screen for deficiencies (B12, thyroid function) and correct under professional guidance.
Select a serum with transparent data and follow recommended application—most serums advise daily application to affected areas.
Complement with scalp-friendly shampoo and conditioners; avoid harsh chemical treatments that stress follicles.
Monitor progress at 3, 6 and 12 months with standardized photos and, if available, objective measures such as colorimetry.
Adjust expectations: expect gradual change; combine topical therapy with lifestyle measures for best outcomes.

Patience and consistent use form the backbone of any credible anti-grey strategy.

FAQ

Q: Do anti-grey hair serums actually work? A: Some serums with plausible mechanisms and clinical data show promise, particularly for early-stage greying or slowing progression. Robust, placebo-controlled trials with objective pigment measures are the strongest evidence. Without such data, efficacy claims remain provisional.

Q: How long before I’ll see results? A: Hair growth rates imply that visible changes will take months. Many product trials report endpoints at 3–6 months or longer. Immediate visual change from serums is unlikely; expect gradual outcomes with consistent application.

Q: Can serums reverse completely white hair? A: Reversing fully white hair is more challenging because the follicular environment may lack viable melanocytes. Serums have a better chance at partially grey hair where melanocyte function is impaired but not absent.

Q: Are these products safe? A: Most topical serums are generally safe, but novel peptides and delivery enhancers carry a risk of sensitization. Dermatologic testing and review of safety data are prudent, especially for those with sensitive skin or scalp disorders.

Q: Should I stop dyeing my hair if I use a serum? A: Not necessarily. Some people may use serums in tandem with dyes—either to reduce dye frequency or maintain color. Check product guidance for compatibility and consult a professional if you use oxidative dyes.

Q: Are oral supplements effective for greying? A: Supplements can correct nutritional deficiencies that contribute to hair problems, but evidence for reversing greying in the absence of deficiency is limited. Use under clinical guidance.

Q: What ingredients should I look for? A: Look for peptides with published mechanisms or trials, antioxidants that address follicular oxidative stress, and formulations optimized for follicular delivery. Ingredient transparency and clinical evidence are more important than marketing claims.

Q: Will genetics overrule these treatments? A: Genetics set a baseline risk and timing for greying, but environmental and lifestyle factors modulate progress. Topical serums can influence local follicular biology, but genetics may limit the extent or speed of response.

Q: How do I choose between brands? A: Prioritize clinical evidence, ingredient transparency, delivery technology and dermatologic tolerability. Trial sizes and money-back guarantees reduce financial risk while you evaluate efficacy.

Q: Is this a fad or a lasting shift? A: Consumer data and market forecasts suggest a lasting shift toward longevity-oriented hair care. However, long-term category resilience will depend on whether products deliver demonstrable benefits and withstand regulatory and clinical scrutiny.

Grey prevention is no longer a fringe aspiration. Market momentum, consumer desire for preventative solutions, and biochemical advances—especially in peptide design and follicular delivery—are turning anti-grey hair serums from aspirational toiletries into an investable segment of hair science. The path from laboratory mechanism to visible hair colour is complex and slow, but the industry’s current trajectory suggests a maturation of both products and evidence. Consumers who balance realistic expectations with rigorous evaluation of claims will be best positioned to separate meaningful innovation from marketing noise.